US equities |
MU $1,029.00 ▲+0.00% SNDK $1,581.82 ▲+0.00% NVDA $229.28 ▲+0.00% INTC $104.70 ▲+0.00% IREN $35.19 ▲+0.00% SPCX $162.57 ▲+0.00% SKHY $169.03 ▲+0.00% TSLA $382.70 ▲+0.00%
FinancialContent

QuidelOrtho Corporation - Common Stock (NQ:QDEL)

13.42 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about QuidelOrtho Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Kaskela Law Firm Announces Investigation of QuidelOrtho Corp. (QDEL) and Encourages Long-Term QDEL Shareholders with Investment Losses to Contact the Firm
From Kaskela Law LLC
Via Business Wire
News headline image
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
QuidelOrtho to Participate in Upcoming Investor Conferences
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Reports First Quarter 2025 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Report First Quarter 2025 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho® Introduces Results Manager™ System
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Announces Appointment of Two Independent Directors to its Board
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Reports Third Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Participate in Three Upcoming Investor Conferences
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Report Third Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Announces New R&D Executive Leader
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer
From QuidelOrtho Corporation
Via Business Wire
News headline image
VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Participate in Upcoming Investor Conferences
From QuidelOrtho Corporation
Via Business Wire
News headline image
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
QuidelOrtho Reports Second Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Report Second Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
DEADLINE TODAY: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important June 11 Deadline in Securities Class Action - QDEL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important June 11 Deadline in Securities Class Action - QDEL
WHY: NEW YORK, NY - (NewMediaWire) - June 10, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation (NASDAQ: QDEL) between February 18,... 
Via TheNewswire.com
Topics Lawsuit
News headline image
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
QUIDELORTHO CORPORATION (NASDAQ: QDEL) FINAL DEADLINE ALERT: Bernstein Liebhard LLP Reminds QuidelOrtho Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >